Michelle Dipp News Today

Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. The firm currently has $36.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $24.00. Several other research firms have also recently weighed […]

Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. Mizuho currently has $36.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $24.00. VSTM has been the topic of a number of […]

Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been assigned an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the stock in the last […]

StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Cantor Fitzgerald restated an overweight rating on shares of Verastem in a research note on […]

StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other reports. HC Wainwright decreased their price objective on Verastem from $3.00 to $2.00 in a report […]

Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among […]

Cantor Fitzgerald reissued their overweight rating on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Verastem’s FY2023 earnings at ($0.26) EPS. A number of other equities analysts have also weighed in on the company. StockNews.com initiated coverage on Verastem […]

Verastem, Inc. (NASDAQ:VSTM – Get Rating) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 1,080,000 shares, a decline of 15.0% from the March 31st total of 1,270,000 shares. Based on an average daily volume of 687,500 shares, the short-interest ratio is presently 1.6 days. Verastem […]

StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other research reports. Mizuho started coverage on Verastem in a report on Wednesday, March 29th. They […]

Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]